There’s a plethora of attractive drug targets in cancer, but their
There’s a plethora of attractive drug targets in cancer, but their therapeutic exploitation proved more challenging than expected, in support of rarely really successful. and redundant success indicators (Igney and Krammer, 2002) (Fig. 1). The idea of truly mitochondriotoxic realtors, inducing organelle collapse (Fantin and Octreotide Leder, 2006) (Fig. 1) materialized using the advancement of … [Read more…]